What is Dermassociates?
Dermassociates Ltd represents a legacy institution in the medical services sector, having provided specialized dermatological care for over five decades. Based in Belleville, Illinois, the practice established a robust market position by addressing critical patient needs, including the management of acne, eczema, psoriasis, and rosacea. Beyond clinical interventions, the firm integrated a retail component through the distribution of dermatologist-grade skin care products, creating a diversified revenue stream. Despite its significant tenure and community impact, the organization is currently navigating a transition phase, with a scheduled cessation of operations in August 2025, marking the conclusion of a multi-generational commitment to regional health care.
How much funding has Dermassociates raised?
Dermassociates has raised a total of $301K across 2 funding rounds:
Debt
$150K
Debt
$151K
Debt (2020): $150K with participation from PPP
Debt (2021): $151K led by PPP
Key Investors in Dermassociates
PPP
Public-Private Partnership
Undisclosed Investors
Undisclosed Investors
What's next for Dermassociates?
As Dermassociates approaches its final operational milestone in late 2025, the focus shifts from growth-oriented capital deployment to the systematic wind-down of clinical assets and the secure transition of patient records. The strategic use of $151K in previous periods provided the necessary liquidity to sustain high-quality care standards during the practice's final years. Moving forward, the primary objective for the leadership team involves ensuring regulatory compliance and continuity of care for the patient base until the September 2025 record-access deadline. This phase represents the final chapter of a long-standing medical enterprise, emphasizing the importance of legacy management and orderly dissolution in the healthcare services industry.
See full Dermassociates company page
